From owner-cardiors@hgmp.mrc.ac.uk Tue Aug 1 13:15:44 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 37EDE17A74; Tue, 1 Aug 2000 13:15:44 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id CA6E017A66; Tue, 1 Aug 2000 13:15:42 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 2673F415DA for ; Tue, 1 Aug 2000 13:15:42 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id NAA21216 for cardiors-list@hgmp.mrc.ac.uk; Tue, 1 Aug 2000 13:15:41 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: A.Shameli@btinternet.com (Ashley Shameli) X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defects Subject: Re: Alternatives to WARFARIN - re: aortic valve surgery Date: Mon, 31 Jul 2000 21:41:37 GMT Organization: BT Internet Lines: 39 Message-ID: <3985ed26.4345458@news.btinternet.com> References: <39851117.45956251@news.btinternet.com> Reply-To: A.Shameli@btinternet.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Newsreader: Forte Agent .99g/32.339 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk On Mon, 31 Jul 2000 13:57:01 +0100, Andy Anderson wrote: >In article <39851117.45956251@news.btinternet.com>, Ashley Shameli > writes >>Hello, >> >>Could anyone point me in the way of information / web links about >>possible alternatives to Warfarin, (probably still being developed) >>which are safter to take? (if such a thing does exist) >> >>Thanks, >>Ashley. >Hi Ashley, >I`m so pleased you mum has at LAST had her surgery but what a long wait >for you all! Good luck. >Go to: www.google.co.uk and do a search. I`ve just done it by using the >words " alternative warfarin heart patients" A lot of info. came up >which may help. Google seems like a great place for info. searching. >pat@aicuk.demon.co.uk >I`m still checking my husband`s heart NG! >Pat >-- >Andy Anderson Pat, Thanks for the information. My mother DID finally get surgery, after her heart had swollen so seriously that her blood pressure still won't go back up to normal from being very low. She only waited 15 months, which is better than the six yeras an elderly woman had waited. NTL, it is all over. Thanks a lot. Ashley From owner-cardiors@hgmp.mrc.ac.uk Wed Aug 2 06:12:45 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 7E5D917B67; Wed, 2 Aug 2000 06:12:45 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 535D317B66; Wed, 2 Aug 2000 06:12:44 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9FF8B415DA for ; Wed, 2 Aug 2000 06:12:43 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id GAA12045 for cardiors-list@hgmp.mrc.ac.uk; Wed, 2 Aug 2000 06:12:43 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "MrDaytonO" X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defects References: <39851117.45956251@news.btinternet.com> Subject: Re: Alternatives to WARFARIN - re: aortic valve surgery Date: Wed, 2 Aug 2000 01:07:49 -0400 Lines: 23 X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.2919.6600 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2919.6600 Message-ID: <3987adbb_1@news.siscom.net> X-Trace: 2 Aug 2000 01:12:27 -0400, ppp166.c5300-1.day-oh.siscom.net Organization: Newshosting.com To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk I was on Warfarin and almost died from it. So was,and did my mother. My Father did die due to using. He had several strokes. Now I and my Mother both are on Plavix,75mg.and an aspirin a day I am on a 325 mg daily cut in half taken half first thing in the morning, and second half at supper time. Mother takes 3 baby aspirins 1 first thing in morning and then one at 6 hours later and last 6 hours later or before bed time with a glass of orange juice. both of us are doing better now, no worries about bleeding to death. We don't have to have blood work all the time now, only every 2 months. Hope this gives you some needed info you needed. MrDaytonO (*-*) "Ashley Shameli" wrote in message news:39851117.45956251@news.btinternet.com... > Hello, > > Could anyone point me in the way of information / web links about > possible alternatives to Warfarin, (probably still being developed) > which are safter to take? (if such a thing does exist) > > Thanks, > Ashley. From owner-cardiors@hgmp.mrc.ac.uk Fri Aug 4 21:46:38 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 07C7A17AFF; Fri, 4 Aug 2000 21:46:37 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id AD57817A8F; Fri, 4 Aug 2000 21:46:36 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id F21AF415DD for ; Fri, 4 Aug 2000 21:46:35 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id VAA25476 for cardiors-list@hgmp.mrc.ac.uk; Fri, 4 Aug 2000 21:46:35 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: A.Shameli@btinternet.com (Ashley Shameli) X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defects Subject: Re: Alternatives to WARFARIN - re: aortic valve surgery Date: Fri, 04 Aug 2000 20:45:46 GMT Organization: BT Internet Lines: 43 Message-ID: <398c9722.9678136@news.btinternet.com> References: <39851117.45956251@news.btinternet.com> <3987adbb_1@news.siscom.net> Reply-To: A.Shameli@btinternet.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Newsreader: Forte Agent .99g/32.339 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Thanks for the reply. I don't suppose you could elaborate, if it's not too personal? I am interested, with my mother just post op, to see all the risks etc. Can I ask if the doctors recommended you stop using Warfarin - they told us the blood tests ensure it is safe. Thanks, Ashley p/s could anyone who replies please CC to my email, a.shameli@btinternet.com My provider has messed up the news feed. On Wed, 2 Aug 2000 01:07:49 -0400, "MrDaytonO" wrote: >I was on Warfarin and almost died from it. So was,and did my mother. > My Father did die due to using. He had several strokes. >Now I and my Mother both are on Plavix,75mg.and an aspirin a day I am on a >325 mg daily cut in half taken half first thing in the morning, and second >half at supper time. Mother takes 3 baby aspirins 1 first thing in morning >and then one at 6 hours later and last 6 hours later or before bed time with >a glass of orange juice. both of us are doing better now, no worries about >bleeding to death. >We don't have to have blood work all the time now, only every 2 months. >Hope this gives you some needed info you needed. >MrDaytonO (*-*) >"Ashley Shameli" wrote in message >news:39851117.45956251@news.btinternet.com... >> Hello, >> >> Could anyone point me in the way of information / web links about >> possible alternatives to Warfarin, (probably still being developed) >> which are safter to take? (if such a thing does exist) >> >> Thanks, >> Ashley. > > From owner-cardiors@hgmp.mrc.ac.uk Sat Aug 5 00:07:28 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 89E6D17B27; Sat, 5 Aug 2000 00:07:28 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 6211617B26; Sat, 5 Aug 2000 00:07:27 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 26D26415DD for ; Sat, 5 Aug 2000 00:07:26 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id AAA27261 for cardiors-list@hgmp.mrc.ac.uk; Sat, 5 Aug 2000 00:07:25 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "Maurice Rodney Baymon" X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defects Subject: Re: Alternatives to WARFARIN - re: aortic valve surgery Date: Fri, 4 Aug 2000 15:53:35 -0700 Organization: Posted via Supernews, http://www.supernews.com Lines: 181 Message-ID: References: <39851117.45956251@news.btinternet.com> <3987adbb_1@news.siscom.net> <398c9722.9678136@news.btinternet.com> Reply-To: "Maurice Rodney Baymon" X-Complaints-To: newsabuse@supernews.com MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_011D_01BFFE2C.25A5C420" X-Newsreader: Microsoft Outlook Express 5.50.4133.2400 X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk This is a multi-part message in MIME format. ------=_NextPart_000_011D_01BFFE2C.25A5C420 Content-Type: text/plain; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable I've been taking Warfarin Sodium (Coumadin) for three or four years now. = I was born in 1950, with a malformed aortic valve, and am awaiting = valve replacement surgery, as the condition of my heart continues to = deteriorate. That's why I've been taking Coumadin, to prevent blood = clots from forming when my atrium fibrillates. It is a hassle to have to go in for regular blood tests, especially = since my veins roll and collapse (referred to as "shy"). Generally they = are difficult to tap into, unless the phlebotomist is really expert (I = call them "vampires"). So, sometimes, it turns into a real ordeal. I = also have to maintain a uniform intake of dark leafy green vegetables. On the other hand, before my doctors arrived at the best Coumadin level, = a blood clot traveled down into my leg. That was one of the worst = experiences of my life (and I've had three brain surgeries). When I = thought about how much damage a clot could do to my brain, I decided the = inconvenience of dealing with Coumadin was a small price to pay. "Ashley Shameli" wrote in message = news:398c9722.9678136@news.btinternet.com... | Thanks for the reply. |=20 | I don't suppose you could elaborate, if it's not too personal? |=20 | I am interested, with my mother just post op, to see all the risks | etc. Can I ask if the doctors recommended you stop using Warfarin - | they told us the blood tests ensure it is safe. |=20 | Thanks, | Ashley |=20 | p/s could anyone who replies please CC to my email, | a.shameli@btinternet.com |=20 | My provider has messed up the news feed. |=20 | On Wed, 2 Aug 2000 01:07:49 -0400, "MrDaytonO" | wrote: |=20 | >I was on Warfarin and almost died from it. So was,and did my mother. | > My Father did die due to using. He had several strokes. | >Now I and my Mother both are on Plavix,75mg.and an aspirin a day I am = on a | >325 mg daily cut in half taken half first thing in the morning, and = second | >half at supper time. Mother takes 3 baby aspirins 1 first thing in = morning | >and then one at 6 hours later and last 6 hours later or before bed = time with | >a glass of orange juice. both of us are doing better now, no worries = about | >bleeding to death. | >We don't have to have blood work all the time now, only every 2 = months. | >Hope this gives you some needed info you needed. | >MrDaytonO (*-*) | >"Ashley Shameli" wrote in message | >news:39851117.45956251@news.btinternet.com... | >> Hello, | >> | >> Could anyone point me in the way of information / web links about | >> possible alternatives to Warfarin, (probably still being developed) | >> which are safter to take? (if such a thing does exist) | >> | >> Thanks, | >> Ashley. | > | > |=20 ------=_NextPart_000_011D_01BFFE2C.25A5C420 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable
I've been taking Warfarin Sodium = (Coumadin) for=20 three or four years now.  I was born in 1950, with a malformed = aortic=20 valve, and am awaiting valve replacement surgery, as the condition of my = heart=20 continues to deteriorate.  That's why I've been taking Coumadin, to = prevent=20 blood clots from forming when my atrium fibrillates.
 
It is a hassle to have to go = in for=20 regular blood tests, especially since my veins roll and collapse = (referred to as=20 "shy").  Generally they are difficult to tap into, unless the=20 phlebotomist is really expert (I call them "vampires").  So,=20 sometimes, it turns into a real ordeal.  I also have to maintain a = uniform=20 intake of dark leafy green vegetables.
 
On the other hand, before my doctors = arrived at=20 the best Coumadin level, a blood clot traveled down into my leg.  = That was=20 one of the worst experiences of my life (and I've had three brain=20 surgeries).  When I thought about how much damage a clot could do = to my=20 brain, I decided the inconvenience of dealing with Coumadin was a small = price to=20 pay.
 
"Ashley Shameli" <A.Shameli@btinternet.com> wrote in = message=20 news:398c9722.9678136@news.btinternet.com...
| Thanks for the reply.
| =
| I don't=20 suppose you could elaborate, if it's not too personal?
|
| I am=20 interested, with my mother just post op, to see all the risks
| etc. = Can I=20 ask if the doctors recommended you stop using Warfarin -
| they told = us the=20 blood tests ensure it is safe.
|
| Thanks,
| Ashley
|
| = p/s=20 could anyone who replies please CC to my email,
| a.shameli@btinternet.com
|
| = My provider=20 has messed up the news feed.
|
| On Wed, 2 Aug 2000 01:07:49 = -0400,=20 "MrDaytonO"
| <pds120da@*nospam*siscom.net> = wrote:
|
|=20 >I was on Warfarin and almost died from it. So was,and did my = mother.
|=20 > My Father did die due to using. He had several strokes.
| = >Now I and=20 my Mother both are on Plavix,75mg.and an aspirin a day I am on a
| = >325 mg=20 daily cut in half taken half first thing in the morning, and second
| = >half at supper time. Mother takes 3 baby aspirins 1 first thing in=20 morning
| >and then one at 6 hours later and last 6 hours later or = before=20 bed time with
| >a glass of orange juice. both of us are doing = better now,=20 no worries about
| >bleeding to death.
| >We don't have to = have=20 blood work all the time now, only every 2 months.
| >Hope this = gives you=20 some needed info you needed.
| >MrDaytonO   (*-*)
|=20 >"Ashley Shameli" <A.Shameli@btinternet.com> wrote in = message
| >news:39851117.45956251@news.btinternet.com...
| = >>=20 Hello,
| >>
| >> Could anyone point me in the way of=20 information / web links about
| >> possible alternatives to = Warfarin,=20 (probably still being developed)
| >> which are safter to take? = (if=20 such a thing does exist)
| >>
| >> Thanks,
| = >>=20 Ashley.
| >
| >
| ------=_NextPart_000_011D_01BFFE2C.25A5C420-- From owner-cardiors@hgmp.mrc.ac.uk Sat Aug 5 14:57:05 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id F0BDD17B64; Sat, 5 Aug 2000 14:56:12 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 7512C17B4D; Sat, 5 Aug 2000 14:55:12 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 2A573415E9 for ; Sat, 5 Aug 2000 14:55:08 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id OAA07576 for cardiors-list@hgmp.mrc.ac.uk; Sat, 5 Aug 2000 14:55:08 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: list@physlink.com (Anton Skorucak) X-Newsgroups: bionet.biology.cardiovascular Subject: Physics and Astronomy ... Date: 5 Aug 2000 14:55:07 +0100 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 69 Message-ID: <142102000865135546550@physlink.com> Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 X-Trace: niobium.hgmp.mrc.ac.uk 965483708 7574 193.62.192.80 (5 Aug 2000 13:55:08 GMT) X-Complaints-To: news@net.bio.net X-Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 06C0B17B46; Sat, 5 Aug 2000 14:54:40 +0100 (BST) X-Received: from mta6.snfc21.pbi.net (mta6.snfc21.pbi.net [206.13.28.240]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0DBD8415DF for ; Sat, 5 Aug 2000 14:54:31 +0100 (BST) X-Received: from physlink.com ([216.103.49.86]) by mta6.snfc21.pbi.net (Sun Internet Mail Server sims.3.5.2000.01.05.12.18.p9) with ESMTP id <0FYT00JQZNXJKG@mta6.snfc21.pbi.net> for cardiors@net.bio.net; Sat, 5 Aug 2000 06:53:43 -0700 (PDT) X-To: "cardiors@net.bio.net" X-EM-Version: 4, 5, 0, 0 X-EM-Registration: #30C3410514B417038530 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk "One thing I have learned in a long life: that all our science, measured against reality, is primitive and childlike - and yet it is the most precious thing we have." - Albert Einstein Are you interested in Physics, Astronomy and Science in general? Then check out Einstein's favorite web site: http://www.physlink.com Here are just some of the things you will find there: - General science reference: Glossary, Physical Constants, Unit Conversion, Astro Constants, Nuclear/Particle Data, Periodic Tables, Materials Safety, Exact Time, Equations, Educator Reference http://www.physlink.com/reference.cfm - FREE weekly physics and astronomy Newsletter http://www.physlink.com/newsletter/signup.cfm - Latest news stories updated daily http://www.physlink.com - Jobs Board: browse and post job ads for physicists, astronomers, mathematicians and engineers. http://www.physlink.com/jobs.cfm - FREE membership in the Physics Teachers Club: get free books, lesson plans, meet other teachers, etc. http://www.physlink.com/teacher_reg.cfm - Ask the Experts: you can send in your physics questions and experts around the world will answer! http://www.physlink.com/ask_experts.cfm - Astronomy links: the most comprehensive source of top astronomy web sites: http://www.physlink.com/astronomy.cfm -Physics and Astronomy Departments Worldwide: comprehensive listing http://www.physlink.com/departments.cfm - FREE science software trial versions, reviews, etc. http://www.physlink.com/software.cfm - Physics FUN: jokes, cartoons, virtual Einstein cards and more ... http://www.physlink.com/fun.cfm ... and much, much more at: http://www.physlink.com ----------------------------------------------------------- If you wish to remove your e-mail address from any future mailings, just click this link: http://www.physlink.com/newsletter/removeoptin.cfm?Email=cardiors@net.bio.ne t (or copy and paste the above link into your browser and hit enter) You were referred to us as someone who is interested in science - if this is not true please accept our apologies for this e-mail. DO NOT REPLY to this e-mail - no human will process the replies - use the above instructions to remove your e-mail from future mailings. Best Regards! --- From owner-cardiors@hgmp.mrc.ac.uk Tue Aug 8 23:06:59 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id D32CB17A91; Tue, 8 Aug 2000 22:52:36 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 9D65717C85; Tue, 8 Aug 2000 22:31:49 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 2A5B9416E2 for ; Tue, 8 Aug 2000 22:23:57 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id WAA09642 for cardiors-list@hgmp.mrc.ac.uk; Tue, 8 Aug 2000 22:23:56 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: A.Shameli@btinternet.com (Ashley Shameli) X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defe Subject: URGENT - help needed for post-op AORTIC VALVE REPLACEMENT - URGENT Date: Tue, 08 Aug 2000 21:19:48 GMT Organization: BT Internet Lines: 51 Message-ID: <39917303.13367261@news.btinternet.com> Reply-To: A.Shameli@btinternet.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Newsreader: Forte Agent .99g/32.339 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Hello, As some helpful members already know, after a long wait (well over a year when she learnt she needed an operation urgently) my mother underwent valve surgery to replace her aortic valve. A little information first which might help:- - the operation took place on Monday 24th July (ie as of today, 08.08.00, two weeks and a day have passed) - and she was let out of hospital on Sunday 6th August - she left the valve replacement to the surgeon, who opted for a carbon-fibre valve because the hole was too small for a pig valve apparently - my mother has SVT, a condition possibly linked to the valve problem according to the surgeon, which resulted in irregular heartbeats a few years ago - the operation took place in the Queen Elizabeth Hospital, Birmingham, England, and was carried out by Mr Keogh and his assistant Mr Satur (if this is relevant) - the doctors/surgeon said when they opened my mother up the heart had swelled very badly, and I am not sure if it has reduced in size yet, so this MIGHT have an afffect on her current condition (see below) Now, the problem is, in the hospital she felt very weak, and the doctors said she had a low blood count. They attributed this to a form of amenia (a result of the operation and NOT a pre-operation condition) and considered a blood transfusion to return the cell count to normal, but opted to go against it and gave her drugs to increase her red-cell count. I understand the weakness post-op is usual, BUT she is still very weak (which she thinks is due to the anemia as she gets breathless after walking even after the operation) and to compliate the situation she is still very tired and she has a temperature. At the Queen Elizabeth Hospital they gave her antibitoics into the vain on a drip for a few days to clear up any infections incase they were in the valve. In hospital this stabalised for 24 hours so she was let out, BUT she has been taking her own temperature at home and it has fluctuated upto 37.8 degrees C, 0.2 degrees below when she has to call the hospital according to the doctors. Now, can anyone shed any information, possibly from past experiences, which can help put her mind at rest. We are all concerned the temperature hasn't subsided - and she is now off the antibitics so a virus at the moment could be very nasty. Thanks for taking the time, Ashley. From owner-cardiors@hgmp.mrc.ac.uk Wed Aug 9 01:12:40 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 2DB2B17ABA; Wed, 9 Aug 2000 01:12:11 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 26E3E17ABA; Wed, 9 Aug 2000 01:11:27 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 52C7C42972 for ; Wed, 9 Aug 2000 00:01:26 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id AAA10778 for cardiors-list@hgmp.mrc.ac.uk; Wed, 9 Aug 2000 00:01:25 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "Carol T" X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defe Subject: Re: URGENT - help needed for post-op AORTIC VALVE REPLACEMENT - URGENT Date: Wed, 9 Aug 2000 00:01:25 +0100 Organization: BT Internet Lines: 23 Message-ID: <8mq3ed$2ps$1@plutonium.btinternet.com> References: <39917303.13367261@news.btinternet.com> X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.2615.200 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2615.200 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Ashley Shameli wrote in message news:39917303.13367261@news.btinternet.com... >>>>> Now, can anyone shed any information, possibly from past experiences, > which can help put her mind at rest. We are all concerned the > temperature hasn't subsided - and she is now off the antibitics so a > virus at the moment could be very nasty.<<<<<< Antibiotics won't get rid of a virus anyway. I read once that if someone takes cold/cool baths it raises the blood count and would help with the temperature. You should speak to her Dr really to find out what's going on, there are medical conditions that raise body temp and also cause palpitations and heart problems. Do you know what her temp was before the operation? I should think that heart surgery is very stressful to get over, not like having a tooth out. Are you sure that everyone isn't fussing her? Carol T From owner-cardiors@hgmp.mrc.ac.uk Wed Aug 9 21:46:10 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 80D0C17ADC; Wed, 9 Aug 2000 21:46:09 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 665BD17ACC; Wed, 9 Aug 2000 21:46:08 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id DC320415CF for ; Wed, 9 Aug 2000 21:46:07 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id VAA05453 for cardiors-list@hgmp.mrc.ac.uk; Wed, 9 Aug 2000 21:46:07 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "Taylor Robbins" X-Newsgroups: bionet.biology.cardiovascular Subject: Great New Cloning Software Lines: 12 X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.3018.1300 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.3018.1300 Message-ID: Date: Wed, 09 Aug 2000 20:45:04 GMT X-Complaints-To: abuse@home.net X-Trace: news2.rdc1.on.home.com 965853904 24.114.172.54 (Wed, 09 Aug 2000 13:45:04 PDT) Organization: Excite@Home - The Leader in Broadband To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk I have been using a program called Redasoft Plasmid for the past year to aid me in my research. Redasoft recently released a beta version of their new program, Visual Cloning 2000. I thought I would recommend it to you all because I am really impressed by the great graphics and new features. Redasoft has added ORF searching, primer design, a sequence viewer, and more web integration. I've tried Vector NTI and a few others, but found them mostly too expensive and confusing. You can download the beta version of Visual Cloning 2000 at http://www.redasoft.com. Dr. Taylor Robbins From owner-cardiors@hgmp.mrc.ac.uk Sun Aug 13 22:52:10 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 5089F17ACE; Sun, 13 Aug 2000 22:52:10 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 3DDAD17ACC; Sun, 13 Aug 2000 22:52:09 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id AD147415D4 for ; Sun, 13 Aug 2000 22:52:08 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id WAA19333 for cardiors-list@hgmp.mrc.ac.uk; Sun, 13 Aug 2000 22:52:08 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f Lines: 2 X-Admin: news@aol.com From: jodileor@aol.com (Jodileor) X-Newsgroups: bionet.biology.cardiovascular Date: 13 Aug 2000 21:51:06 GMT Organization: AOL http://www.aol.com Subject: aortic valve Message-ID: <20000813175106.28101.00000296@ng-fe1.aol.com> To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk This I am told creates an enlarged heart. Is it advisable to have surgery? I'm 73 Thanks, Mary From owner-cardiors@hgmp.mrc.ac.uk Sat Aug 19 19:10:08 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id A46DE17A4E; Sat, 19 Aug 2000 19:10:07 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 73F6517A43; Sat, 19 Aug 2000 19:10:06 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id A3B57415DD for ; Sat, 19 Aug 2000 19:10:05 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id TAA14238 for cardiors-list@hgmp.mrc.ac.uk; Sat, 19 Aug 2000 19:10:05 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "John F. Black" X-Newsgroups: bionet.biology.cardiovascular Subject: Bio /anatomy Questions Date: Sat, 19 Aug 2000 17:40:24 +0930 Organization: JBPC X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.50.4133.2400 X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400 Lines: 11 Message-ID: <399ecd79$0$431$603e2862@news.adl.ihug.com.au> X-Trace: 966708601 news.adl.ihug.com.au 431 203.30.124.105 X-Complaints-To: abuse@ihug.com.au To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Hi, can somebody help with the following queries? What is the largest cell in the body? Which lung is the smaller? What is the name of the two lines that run from your top lip to your nose? Women or men's hearts beat faster? What is the body's largest internal organ? Hope some one can help gran-daughter for school assignment. jaybee@iweb.net.au From owner-cardiors@hgmp.mrc.ac.uk Sun Aug 20 01:47:17 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id D5DC717A95; Sun, 20 Aug 2000 01:47:16 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 8041B17A91; Sun, 20 Aug 2000 01:47:15 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id D38C3415DA for ; Sun, 20 Aug 2000 01:47:14 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id BAA27507 for cardiors-list@hgmp.mrc.ac.uk; Sun, 20 Aug 2000 01:47:14 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "kanda" X-Newsgroups: bionet.biology.cardiovascular Subject: Want to Buy: Pre-owned Laboratory Equipment Lines: 56 X-Newsreader: Microsoft Outlook Express 4.72.3110.5 X-MimeOLE: Produced By Microsoft MimeOLE V4.72.3110.3 Message-ID: Date: Sat, 19 Aug 2000 20:41:59 -0400 X-Complaints-To: abuse@globetrotter.net X-Trace: news.globetrotter.net 966732433 142.169.183.91 (Sat, 19 Aug 2000 20:47:13 EDT) Organization: GlobeTrotter To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk We urgently need the following pre-owned lab items: 1. Millipore Pellicon 2/Pellicon cassette system 2. Pharmacia FPLC with full configuration 3. HPLC 1100, HP model, without autosampler 4. UV/Vis spectrophotometer; recent model; kinetics and scanning capabilities 5. Power supplies; Pharmacia, Hoefer, or BioRad model; 500V and 2000V 6. High speed centrifuge: benchtop; very recent Beckman model 7. Thermostatic circulator; Pharmacia MultiTemp III model 8. Inverted Microscope with camera; biological application; Nikon, Olympus, or Zeiss recent model 9. electrophoresis gel image analysis system with fluorescence and UV application 10. Microplate reader: very recent Bio-Tek, Molecular device or Labsystems model 11. Microplate fluorescence reader: recent model 12. PCR system; Perkin Elmer 9600 or 9700 13. pH meter 14. Balance; top loading; 0.001g unit 15. Water purifucation system; Milli Q and Milli RO or Barnstead Easy Pure RO and NanoPure ; recent tabletop 16. Vacuum gel dryer system; Hoefer model 17. Complete Speed-Vac system for protein purifucation; Savant model 18. microcentrifuge, refrigerated; recent Eppendorf model 19. microcentrifuge; recent Eppendorf model 20. tabletop centrifuge with adaptor for 50ml conical tube, refrigerated; recent model 21. Deep Freezer: Revco or Forma model; about 300L or 500 L; -86C 22. Shaker, oscilator type; Hoefer 23. Shaker, orbital type; Hoefer 24. Vortex mixer (Genie 2) 25. Stirrer (Labline, Thermolyne, Corning, etc.) 26. Hot plate stirrer (Labline, Thermolyne, Corning, etc.) 27. Transilluminator; UV/Vis; Hoefer 28. Photodocumentation system (PhotoMan direct gel documentation system); Hoefer 29. Electrophoresis system; recent Novex model 30. BD FACSort Cell Sorter 31. Perkin Elmer ABI 377 DNA Sequencer If you have any of the above items or know anybody willing to sell please contact me. Please submit offers with full specs, pictures and pricing. You can also submit your offers to sell using our classified ads section at http://www.biomedika.com Registration and Postings are FREE! Thanks. Kanda Tel. 1-514-684-0226 kanda@biomedika.com From owner-cardiors@hgmp.mrc.ac.uk Sun Aug 20 02:10:01 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 5956017A9C; Sun, 20 Aug 2000 02:10:01 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 15F7017A9A; Sun, 20 Aug 2000 02:10:00 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 766D0415DA for ; Sun, 20 Aug 2000 02:09:59 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA27851 for cardiors-list@hgmp.mrc.ac.uk; Sun, 20 Aug 2000 02:09:58 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Doug Skrecky X-Newsgroups: bionet.biology.cardiovascular,sci.life-extension Subject: pravastatin is safer than other statins Date: 20 Aug 2000 01:03:24 GMT Organization: Vancouver CommunityNet Lines: 31 Message-ID: <8nnaos$ov1$1@sylvester.vcn.bc.ca> X-Trace: sylvester.vcn.bc.ca 966733404 25569 207.102.64.2 (20 Aug 2000 01:03:24 GMT) X-Complaints-To: sys-admin@vcn.bc.ca User-Agent: tin/pre-1.4-19990805 ("Preacher Man") (UNIX) (SunOS/5.7 (sun4u)) To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Title Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs. Source Journal of Cardiovascular Pharmacology. 35(2):256-62, 2000 Feb. Abstract Pretreatment of dogs with simvastatin, a lipophilic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, increases myocardial contractile dysfunction during reperfusion after ischemia (stunning), with reduction of tissue adenosine triphosphate (ATP). This was thought to be a consequence of prevention of ubiquinone biosynthesis by the lipophilic inhibitor in the myocardial cell. We examined whether other lipophilic HMG-CoA reductase inhibitors also influence myocardial stunning in dogs. Vehicle, atorvastatin (2 mg/ kg/day), fluvastatin (4 mg/kg/day), or cerivastatin (40 microg/kg/ day) was orally administered for 3 weeks. Hydrophilic pravastatin (4 mg/kg/day) also was given. After 3 weeks, pentobarbital-anesthetized dogs were subjected to 15-min left anterior descending coronary artery occlusion followed by 2-h reperfusion. Myocardial segment function was determined by sonomicrometry. Tissue levels of ATP were determined in 2-h reperfused hearts. All inhibitors significantly decreased serum cholesterol level. The three lipophilic inhibitors resulted in a worsening of segment function in the reperfused myocardium, as compared with the vehicle group. The levels of ATP in the atorvastatin, fluvastatin, and cerivastatin groups were significantly lower than that in the vehicle group. These results confirm that lipophilic HMG-CoA reductase inhibitors enhance myocardial stunning in association with ATP reduction after ischemia and reperfusion. From owner-cardiors@hgmp.mrc.ac.uk Sun Aug 20 02:11:00 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 6012217A9D; Sun, 20 Aug 2000 02:11:00 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 4D65817A9C; Sun, 20 Aug 2000 02:10:59 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id AB367415DA for ; Sun, 20 Aug 2000 02:10:58 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA27855 for cardiors-list@hgmp.mrc.ac.uk; Sun, 20 Aug 2000 02:10:58 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Doug Skrecky X-Newsgroups: bionet.biology.cardiovascular,sci.life-extension Subject: ramipril may be the best ACE inhibitor Date: 20 Aug 2000 01:04:23 GMT Organization: Vancouver CommunityNet Lines: 31 Message-ID: <8nnaqn$ov1$2@sylvester.vcn.bc.ca> X-Trace: sylvester.vcn.bc.ca 966733463 25569 207.102.64.2 (20 Aug 2000 01:04:23 GMT) X-Complaints-To: sys-admin@vcn.bc.ca User-Agent: tin/pre-1.4-19990805 ("Preacher Man") (UNIX) (SunOS/5.7 (sun4u)) To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Title Ramipril vs captopril in mild to moderate hypertension. Source Journal of the Association of Physicians of India. 42(2):120-3, 1994 Feb. Abstract Ramipril 5 mg once daily was compared to Captopril 50 mg twice daily in a randomised, double-blind, parallel group study in 60 patients with a diastolic blood pressure between 95 to 120 mmHg over a period of 2 months. Both drugs in the dose regimen used in this study exerted a similar anti-hypertensive effect at the end of 2 months of treatment resulting in a fall of supine diastolic blood pressure with Ramipril = 19.27 +/- 3.34 mmHg and Captopril = 19.15 +/- 2.63, in patients receiving the drugs without the diuretic. The mean fall in supine diastolic blood pressure 4 hours after the first dose of Ramipril was 6.5 mmHg and Captopril 8 mmHg. None of the patients developed first dose hypotension or orthostatic hypotension and there was no significant alteration of the heart rate in either group. The serum K+ levels remained unchanged in both groups of patients. Both drugs were well tolerated and there were no adverse effects observed on the liver, kidney, blood sugar or haemopoietic system. Based on the results of this study, it can be concluded that the antihypertensive efficacy of 5 mg ramipril in a once daily dose is equivalent to 50 mg captopril given twice daily. However an appreciably greater number of patients reported improvement in the "quality of life' parameters with ramipril as compared to captopril. Thus for the routine treatment of mild to moderate arterial hypertension, ramipril offers reliable antihypertensive efficacy in a once daily dose, thereby helping to improve patient compliance and making the treatment more economical. From owner-cardiors@hgmp.mrc.ac.uk Mon Aug 21 21:15:34 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id DE8DD17AE6; Mon, 21 Aug 2000 21:15:33 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id A148017AD3; Mon, 21 Aug 2000 21:15:30 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id BBC91415DC for ; Mon, 21 Aug 2000 21:15:29 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id VAA09208 for cardiors-list@hgmp.mrc.ac.uk; Mon, 21 Aug 2000 21:15:29 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: A.Shameli@btinternet.com (Ashley Shameli) X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defect Subject: Post Aortic-Valve Replacement Walking Date: Mon, 21 Aug 2000 20:13:52 GMT Organization: BT Internet Lines: 15 Message-ID: <39a28ce6.9952060@news.btinternet.com> Reply-To: A.Shameli@btinternet.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Newsreader: Forte Agent .99g/32.339 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Dear members, I have noticed a lot about people post bypass being meant to walk. My mother, now three days off one month post-op from an aortic valve replacement, has had no such advice and has done very little excercise. Should she start doing some? Thanks, Ashley a.shameli@btinternet.com From owner-cardiors@hgmp.mrc.ac.uk Tue Aug 22 02:17:02 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id DD27D17A65; Tue, 22 Aug 2000 02:17:00 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id B6B3A17A75; Tue, 22 Aug 2000 02:16:58 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 100CA415DA for ; Tue, 22 Aug 2000 02:16:57 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA20554 for cardiors-list@hgmp.mrc.ac.uk; Tue, 22 Aug 2000 02:16:57 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f Message-ID: <39A1D4F4.DDA9ED97@goibsmail.com> Date: Mon, 21 Aug 2000 21:18:53 -0400 X-Mailer: Mozilla 4.7 (Macintosh; U; PPC) X-Accept-Language: en MIME-Version: 1.0 X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defects Subject: Re: Post Aortic-Valve Replacement Walking References: <39a28ce6.9952060@news.btinternet.com> Content-Type: text/plain; charset=us-ascii; x-mac-type="54455854"; x-mac-creator="4D4F5353" Content-Transfer-Encoding: 7bit Lines: 15 X-Comments: This message did not originate from the Sender address. It was posted through Newsfeeds.com's exclusive, publicly accessible anonymous Usenet Server. X-Comments2: IMPORTANT: Newsfeeds.com does not condone, nor support, spam or any illegal or copyrighted postings. X-Comments3: IMPORTANT: Under NO circumstances will postings containing illegal or copyrighted material through this service be tolerated!! X-Report: Please report illegal or inappropriate use to You may also use our online abuse reporting form: http://www.newsfeeds.com/abuseform.htm X-Abuse-Info: Please be sure to forward a copy of ALL headers, INCLUDING the body (DO NOT SEND ATTACHMENTS) From: Anonymous Organization: Newsfeeds.com http://www.newsfeeds.com 73,000+ UNCENSORED Newsgroups. To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Yes, she should begin. I (59 YO Male) began walking around the kitchen, dining room, living room for a few days 1 week post op. Then went out to a parking lot (didn't like that). Then around the block. Then 1/4 mile on level streets 3rd week. Then worked up to 2 miles, 3 miles and then my standard 3.5 mile walk with hills, 12 week post-op. It's good for your circulation and peace of mind. (I was fortunate to walk throughout spring-time in Maryland. Beautiful. --------== Posted Anonymously via Newsfeeds.Com ==------- Featuring the worlds only Anonymous Usenet Server -----------== http://www.newsfeeds.com ==---------- From owner-cardiors@hgmp.mrc.ac.uk Tue Aug 22 11:30:12 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 55F3317B33; Tue, 22 Aug 2000 11:30:11 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id EE8E117B0A; Tue, 22 Aug 2000 11:30:08 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 07FE2415DA for ; Tue, 22 Aug 2000 11:30:07 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id LAA27193 for cardiors-list@hgmp.mrc.ac.uk; Tue, 22 Aug 2000 11:30:07 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: juan X-Newsgroups: bionet.biology.cardiovascular Subject: Re: ramipril may be the best ACE inhibitor Date: Tue, 22 Aug 2000 12:20:42 +0200 Organization: Medtronic Inc. Lines: 40 Message-ID: <39A253FA.14F97A4A@nonspam.yahoo.com> References: <8nnaqn$ov1$2@sylvester.vcn.bc.ca> Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Trace: gazette.corp.medtronic.com 966939647 16230 144.15.246.10 (22 Aug 2000 10:20:47 GMT) X-Complaints-To: usenet@medtronic.com X-Mailer: Mozilla 4.72 [en] (Win98; I) X-Accept-Language: en To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk OK, I am beginning with the subject of cardiololgy. In your mail, Doug, you talk about the bettect,er behaviour of ramipril vs captopril treating hypertension, but in the subject you talk about the best ACE inhibitor. What has to do one thing with the other? is there any relationship? Thank you juan Doug Skrecky wrote: > Title > Ramipril vs captopril in mild to moderate > hypertension. > Source > Journal of the Association of Physicians of India. 42(2):120-3, 1994 Feb. > Abstract > Ramipril 5 mg once daily was compared to > Captopril 50 mg twice daily in a randomised, double-blind, > parallel group study in 60 patients with a diastolic blood pressure between > 95 to 120 mmHg over a period of 2 months. Both drugs in the dose regimen used > in this study exerted a similar anti-hypertensive effect at the end of 2 > months of treatment resulting in a fall of supine diastolic blood pressure > with Ramipril = 19.27 +/- 3.34 mmHg and > Captopril = 19.15 +/- 2.63, in patients receiving the drugs > without the diuretic. The mean fall in supine diastolic blood pressure 4 > hours after the first dose of Ramipril was 6.5 mmHg and > Captopril 8 mmHg. None of the patients developed first dose > hypotension or orthostatic hypotension and there was no significant > alteration of the heart rate in either group. The serum K+ levels remained > unchanged in both groups of patients. Both drugs were well tolerated and > there were no adverse effects observed on the liver, kidney, blood sugar or > haemopoietic system. Based on the results of this study, it can be concluded > that the antihypertensive efficacy of 5 mg ramipril in a > once daily dose is equivalent to 50 mg captopril given twice > daily. However an appreciably greater number of patients reported improvement > in the "quality of life' parameters with ramipril as > compared to captopril. Thus for the routine treatment of > mild to moderate arterial hypertension, ramipril offers > reliable antihypertensive efficacy in a once daily dose, thereby helping to > improve patient compliance and making the treatment more economical. From owner-cardiors@hgmp.mrc.ac.uk Wed Aug 23 02:36:59 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 248DA17B85; Wed, 23 Aug 2000 02:36:59 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 11E0317B84; Wed, 23 Aug 2000 02:36:57 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 70951415DD for ; Wed, 23 Aug 2000 02:36:57 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA17012 for cardiors-list@hgmp.mrc.ac.uk; Wed, 23 Aug 2000 02:36:57 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: investoredu@yahoo.com X-Newsgroups: bionet.biology.cardiovascular Subject: FREE Dow Jones Video! Date: 23 Aug 2000 02:36:55 +0100 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 42 Message-ID: <200008230136.SAA08793@harrier.prod.itd.earthlink.net> Mime-Version: 1.0 Content-Type: text/plain; charset=unknown-8bit X-Trace: niobium.hgmp.mrc.ac.uk 966994616 17010 193.62.192.80 (23 Aug 2000 01:36:56 GMT) X-Complaints-To: news@net.bio.net X-Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id D370017B84; Wed, 23 Aug 2000 02:36:54 +0100 (BST) X-Received: from harrier.prod.itd.earthlink.net (harrier.prod.itd.earthlink.net [207.217.121.12]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 43075415DC for ; Wed, 23 Aug 2000 02:36:53 +0100 (BST) X-Received: from helvm (sdn-ar-001okocitP241.dialsprint.net [168.191.182.3]) by harrier.prod.itd.earthlink.net (8.9.3-EL_1_3/8.9.3) with SMTP id SAA08793 for cardiors@net.bio.net; Tue, 22 Aug 2000 18:36:50 -0700 (PDT) X-To: To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk FREE INVESTMENT VIDEO Due to oversupplies and a lack of Asian demand, the prices of corn, wheat, and soybeans are at the lowest prices we have seen in 20 years! However, with a significant drought in some major grain growing areas and early signs of an economic recovery in Asia we feel that grain prices could increase substantially. Learn how to speculate in the grain markets by leveraging 25,000 bushels of corn, wheat, soybeans. Request you FREE video now! Simply fill our our short form below. Free Video Order Form First Name:__________________ Last Name:___________________ Address:_____________________ City:________________________ State:_______________________ Zip Code:____________________ Home Phone:( ) - Work Phone:( ) - Fax Number:( ) - Best Time To Call?___________ Where To Call?_______________ --- From owner-cardiors@hgmp.mrc.ac.uk Wed Aug 23 23:37:33 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id BDA6E17B47; Wed, 23 Aug 2000 23:37:32 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 4886317B29; Wed, 23 Aug 2000 23:37:31 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 55F80415DC for ; Wed, 23 Aug 2000 23:37:30 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id XAA11040 for cardiors-list@hgmp.mrc.ac.uk; Wed, 23 Aug 2000 23:37:29 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Doug Skrecky X-Newsgroups: bionet.biology.cardiovascular,sci.life-extension,sci.med.nutrition Subject: policosanol may be the best lipid lowering supplement Date: 23 Aug 2000 22:30:50 GMT Organization: Vancouver CommunityNet Lines: 161 Message-ID: <8o1jaq$hqi$1@sylvester.vcn.bc.ca> X-Trace: sylvester.vcn.bc.ca 967069850 18258 207.102.64.2 (23 Aug 2000 22:30:50 GMT) X-Complaints-To: sys-admin@vcn.bc.ca User-Agent: tin/pre-1.4-19990805 ("Preacher Man") (UNIX) (SunOS/5.7 (sun4u)) To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Citations: 1-5 <1> Title [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia]. [Spanish] Source Revista Medica de Chile. 127(3):286-94, 1999 Mar. Abstract BACKGROUND: Policosanol is a new cholesterol lowering agent derived from sugar cane. AIM: To compare the cholesterol lowering efficacy of policosanol with HMG CoA inhibitors. PATIENTS AND METHODS: Patients with a LDL cholesterol over 160 mg/dl were studied. If, after 6 weeks of diet, cholesterol persisted elevated, they were doubly blind randomized to receive policosanol 10 mg/day (55 patients), lovastatin 20 mg/day (26 patients) or simvastatin 10 mg/day (25 patients). Serum cholesterol was measured again after 8 weeks of therapy. RESULTS: Initial demographic and laboratory data were similar among treatment groups. A 24% LDL cholesterol reduction was obtained with policosanol, compared with a 22% reduction with lovastatin and a 15% reduction with simvastatin. HDL cholesterol significantly increased in patients on policosanol and did not change in the other treatment groups. Adverse effects of policosanol were mild and unspecific. No changes in hepatic enzymes were observed. CONCLUSIONS: Policosanol is a safe and effective cholesterol reducing agent. <2> Title Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Source Clinical Pharmacology & Therapeutics. 65(4):439-47, 1999 Apr. Abstract INTRODUCTION: This study was undertaken to evaluate the efficacy, safety, and tolerability of policosanol, a new cholesterol-lowering drug, in patients with type II hypercholesterolemia and additional coronary risk factors. PATIENTS AND METHODS: After 5 weeks of a standard step-1 lipid-lowering diet, 437 patients were randomized to receive, under double-blind conditions, 5 mg policosanol or placebo once a day with the evening meal for 12 weeks and 10 mg policosanol or placebo for the next 12 weeks. RESULTS: Both groups were similar at randomization. Policosanol (5 and 10 mg/day) significantly reduced (P < .001) serum low-density lipoprotein cholesterol (18.2% and 25.6%, respectively) and cholesterol (13.0% and 17.4%), and it significantly raised (P < .01) high-density lipoprotein cholesterol (15.5% and 28.4%). Triglycerides remained unchanged after the first 12 weeks and lowered significantly (5.2%; P < .01) at study completion. Policosanol was safe and well tolerated, and no drug-related disturbances were observed. Two male patients who received placebo died during the study--one because of a myocardial infarction and the other because of a cardiac arrest that occurred during a surgical intervention. There were 11 serious adverse events (5.1%) in 10 patients who received placebo (4.6%), 7 of which were vascular, compared with no serious adverse events reported in patients receiving policosanol (P < .01). CONCLUSIONS: Subjects in the group treated with policosanol did not have serious adverse events during the 24-week study. This study shows that policosanol is effective, safe, and well tolerated in patients with hypercholesterolemia and concomitant coronary risk factors. <3> Title A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication. Source Angiology. 50(2):123-30, 1999 Feb. Abstract This study was undertaken to evaluate the efficacy and tolerability of policosanol, a new cholesterol-lowering drug with concomitant antiplatelet effects, in patients with intermittent claudication. After a baseline period of 6 weeks, 62 patients were randomized to receive, under double-blind conditions, either placebo (31 patients) or policosanol (31), 10 mg twice daily. Walking distances in a treadmill (constant speed 3.2 km/hr, slope 10 degrees) were assessed before and after 6 months of treatment. Both groups were similar at randomization. Policosanol increased significantly (p < 0.01) the initial claudication distance from 132.5+/-13.5 m (baseline) to 205.7+/-36.3 m (after therapy) and the absolute claudication distance (p<0.0001) from 229.5+/-22.0 m to 365.4+/-46.9 m; meanwhile both variables remained unchanged in the placebo group (p<0.05). The reduction of lower limb symptoms showed a greater benefit in the policosanol group. There was no significant change in either group in the ankle/arm pressure ratio. The treatment was well tolerated. There were 10 discontinuations (seven placebo, three policosanol) from the study. Six withdrawals occurred because of adverse events (AE); all were in placebo patients. There were five serious vascular AEs in the placebo group but none in the policosanol group (p<0.05). Overall, 12/31 (38.7%) placebo patients and 3/31 (9.7%) policosanol patients experienced AEs after randomization, which showed a lesser incidence of AEs in the policosanol group (p<0.01). The present study demonstrates a beneficial effect of policosanol in patients with intermittent claudication. <4> Title Effect of policosanol on intimal thickening in rabbit cuffed carotid artery. Source International Journal of Cardiology. 67(2):125-32, 1998 Dec 1. Abstract We studied the effect of policosanol on smooth muscle cell proliferation in the cuffed carotid artery of the rabbit. Policosanol is a mixture of higher aliphatic primary alcohols isolated from sugar cane wax, with cholesterol lowering effects proved in experimental models and patients with type II hypercholesterolemia. It acts by inhibiting cholesterol biosynthesis. The positioning of a nonocclusive silicone collar around the rabbit carotid artery results in the formation of a neointima. We wished to determine whether policosanol orally administered prevented intimal thickening. Collars were placed around the left carotid for 15 days. The contralateral artery was sham operated. We included three experimental groups: a control received vehicle and two others policosanol at 5 and 25 mg Kg until sacrificed. Samples of arteries were examined by light and electron microscopy. To evaluate intimal thickening the cross-sectional area of intima and media were measured. Neointima was significantly reduced in policosanol-treated animals compared with controls. The smooth muscle cell proliferation was studied by the immunohistochemical detection of proliferating cell nuclear antigen and a significant reduction was observed in policosanol treated rabbits. It is concluded that policosanol has a protective effect on the neointima formation in this experimental model. <5> Title Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients. Source International Journal of Clinical Pharmacology & Therapeutics. 36(9):469-73, 1998 Sep. Abstract This study examined the effects of long-term lipid-lowering therapy with policosanol on the clinical evolution, and exercise-ECG testing responses of 45 coronary heart disease (CHD) patients with myocardial ischemia, documented by exercise 201T1-myocardial perfusion scintigraphy, in an overall randomized, double-blind, placebo-controlled trial, made for different test endpoints. Fifteen patients were treated with 5 mg of policosanol twice daily; another 15 patients were administered the same drug dose plus 125 mg aspirin; and the other 15 patients received placebo plus equal aspirin dose. They were followed for 20 months, previous baseline observations, with treadmill exercise-ECG, besides serum lipid test. Beneficial changes on proportions among the 2 policosanol groups and the placebo group, showed an increment on functional capacity class, a decrement on rest and exercise angina, and a significant decrease in cardiac events, and in ischemic ST segment response, especially in the policosanol plus aspirin group (p = 0.05, X2(2df) = 5.8; p = 0.04, p = 0.02; Fisher). After treatment, sets of mean changes revealed an increase on maximum oxygen uptake, and a decline on double product simultaneously in both policosanol groups (p < or = 0.02, p < or = 0.002; Pillais, Hotellings' T2), while the placebo group was impaired. Aerobic functional capacity percent showed an increment in policosanol groups (p < or = 0.05, paired T). Lipid levels improved as other endpoints already reported. A supposed ergogenic effect of octacosanol, policosanol's main active compound, was not detected with this design. These results show that policosanol-treated CHD patients improved clinical evolution, and exercise-ECG responses, owing to the amelioration of myocardial ischemia, even more when administered with aspirin. From owner-cardiors@hgmp.mrc.ac.uk Thu Aug 24 12:37:24 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id B697617ABB; Thu, 24 Aug 2000 12:37:23 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 7327917A9E; Thu, 24 Aug 2000 12:37:22 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id D9157415DD for ; Thu, 24 Aug 2000 12:37:21 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id MAA20422 for cardiors-list@hgmp.mrc.ac.uk; Thu, 24 Aug 2000 12:37:21 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "Arbub" X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defect References: <39a28ce6.9952060@news.btinternet.com> Subject: Re: Post Aortic-Valve Replacement Walking Lines: 26 X-Newsreader: Microsoft Outlook Express 4.72.3110.1 X-MimeOLE: Produced By Microsoft MimeOLE V4.72.3155.0 Message-ID: Date: Thu, 24 Aug 2000 12:33:41 +0100 X-Trace: NewsReader 967116912 62.6.215.145 (Thu, 24 Aug 2000 12:35:12 BST) To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Ashley Shameli wrote in message <39a28ce6.9952060@news.btinternet.com>... >Dear members, > >I have noticed a lot about people post bypass being meant to walk. > >My mother, now three days off one month post-op from an aortic valve >replacement, has had no such advice and has done very little >excercise. Walking certainly seems to be the number one recommendation. My cardiac exercise adviser recommended building up from (virtually) nothing to 1.5 miles in 45 minutes over a 6-week period. That, or course, assumes that 1.5 miles in 45 minutes was 'normal' *before* the operation. One problem, of course is horizontal versus vertical distance. A mile uphill is *much* more demanding that a mile on the flat. Aspirations/personal targets seem to range from half a mile to seven miles daily. YMMV even more!! My adviser also mentioned that (especially if you live in a hilly area) an exercise bike or similar was just as good, from the body's point of view. HTH GT From owner-cardiors@hgmp.mrc.ac.uk Thu Aug 24 14:02:06 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 0AC8217ACA; Thu, 24 Aug 2000 14:02:05 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 9324117AB9; Thu, 24 Aug 2000 14:02:04 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id EE85E415D5 for ; Thu, 24 Aug 2000 14:02:03 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id OAA21546 for cardiors-list@hgmp.mrc.ac.uk; Thu, 24 Aug 2000 14:02:03 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Tony Sayer X-Newsgroups: uk.people.health,sci.med.cardiology,own.health.misc,misc.health,bionet.biology.cardiovascular,alt.support-heart,alt.support.heart-defect Subject: Re: Post Aortic-Valve Replacement Walking Date: Thu, 24 Aug 2000 14:00:23 +0100 Organization: tony Message-ID: References: <39a28ce6.9952060@news.btinternet.com> X-NNTP-Posting-Host: bancom.demon.co.uk:194.222.184.169 X-Trace: news.demon.co.uk 967122065 nnrp-10:20415 NO-IDENT bancom.demon.co.uk:194.222.184.169 X-Complaints-To: abuse@demon.net MIME-Version: 1.0 X-Newsreader: Turnpike Integrated Version 4.02 U Lines: 42 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk In article , Arbub dictates > >Ashley Shameli wrote in message <39a28ce6.9952060@news.btinternet.com>... >>Dear members, >> >>I have noticed a lot about people post bypass being meant to walk. >> >>My mother, now three days off one month post-op from an aortic valve >>replacement, has had no such advice and has done very little >>excercise. > >Walking certainly seems to be the number one recommendation. My cardiac >exercise adviser recommended building up from (virtually) nothing to 1.5 >miles in 45 minutes over a 6-week period. That, or course, assumes that 1.5 >miles in 45 minutes was 'normal' *before* the operation. >One problem, of course is horizontal versus vertical distance. A mile >uphill is *much* more demanding that a mile on the flat. >Aspirations/personal targets seem to range from half a mile to seven miles >daily. YMMV even more!! My adviser also mentioned that (especially if you >live in a hilly area) an exercise bike or similar was just as good, from the >body's point of view. > >HTH > >GT > > Looking at the American sites re heart trouble, hypertension etc. ALL of them seem to recommend excersise as something of a wonder drug!. -- Tony Sayer Bancom Communications Ltd U.K. Tel +44 1223 566577 Fax +44 1223 566588 P.O. Box 280, Cambridge, England, CB2 2DY E-Mail tony@bancom.demon.co.uk TL447-553 52* 10.57'N 0* 6.96 E From owner-cardiors@hgmp.mrc.ac.uk Fri Aug 25 20:49:57 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 88C5E17B67; Fri, 25 Aug 2000 20:44:26 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 50F0017B67; Fri, 25 Aug 2000 20:41:08 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9BC77415DE for ; Fri, 25 Aug 2000 20:41:07 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id UAA22658 for cardiors-list@hgmp.mrc.ac.uk; Fri, 25 Aug 2000 20:41:07 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "kanda" X-Newsgroups: bionet.biology.cardiovascular Subject: New Online Equipment Classifieds at http://www.biomedika.com Lines: 19 X-Newsreader: Microsoft Outlook Express 4.72.3110.5 X-MimeOLE: Produced By Microsoft MimeOLE V4.72.3110.3 Message-ID: Date: Fri, 25 Aug 2000 15:35:20 -0400 X-Complaints-To: abuse@globetrotter.net X-Trace: news.globetrotter.net 967232464 142.169.174.199 (Fri, 25 Aug 2000 15:41:04 EDT) Organization: GlobeTrotter To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Buy, sell, trade or donate pre-owned medical, laboratory, clinical or process equipment using our online classifieds. Use our Online Medical Directory to locate physicians, dentists, pharmacists, medical clinics, hospitals or other healthcare resources worldwide. Post offers, tenders or RFP about R&D projects, innovations, patents, partneships, investments, funds, contracts, equipment, supply source opportunities. Use our online catalog to buy medical supplies, generic drugs, diagnostic reagents, equipment, etc. Free registration to our online referral directory! For more information visit ou web site at: http://www.biomedika.com Thanks. Kanda kanda@biomedika.com Tel. 1-514-684-0226 From owner-cardiors@hgmp.mrc.ac.uk Sat Aug 26 08:49:24 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id DBB7C17B1D; Sat, 26 Aug 2000 08:49:23 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 5D64B17A88; Sat, 26 Aug 2000 08:49:22 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 8E150415DC for ; Sat, 26 Aug 2000 08:49:21 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id IAA09833 for cardiors-list@hgmp.mrc.ac.uk; Sat, 26 Aug 2000 08:49:21 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f Reply-To: "Rune Falk" From: "Rune Falk" X-Newsgroups: bionet.biology.cardiovascular Subject: thoracic & cardiovascular surgery HELP Lines: 16 X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.50.4133.2400 X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400 Message-ID: <%CKp5.57$Vg6.360@news01.chello.no> Date: Sat, 26 Aug 2000 07:48:11 GMT X-Complaints-To: abuse@chello.no X-Trace: news01.chello.no 967276091 212.186.237.152 (Sat, 26 Aug 2000 09:48:11 MET DST) Organization: chello broadband Norway To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Currently i am a 4th year medical student who is about to take on elective project in Thoracic & Cardiovascular Surgery in one of the teaching hospital in Norway. I would welcome any suggestion of project that would be interesting and beneficial to take on. I have completed only 1 year of clinical training which mainly involving history taking and investigation. Any suggestion would be most appreciated. med stu Norliza leeza29@hotmail.com rfalk@chello.no From owner-cardiors@hgmp.mrc.ac.uk Sun Aug 27 15:44:05 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id D26F017D9E; Sun, 27 Aug 2000 15:44:04 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 8FA3D17AE1; Sun, 27 Aug 2000 15:44:03 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0FC5C415E7 for ; Sun, 27 Aug 2000 15:44:03 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id PAA10526 for cardiors-list@hgmp.mrc.ac.uk; Sun, 27 Aug 2000 15:44:02 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: lynndoon@123india.com X-Newsgroups: bionet.biology.cardiovascular Subject: Investors Please Read - Strong Buy Recommendation on UVGI, please buy Today and double your money Date: 27 Aug 2000 15:44:01 +0100 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 109 Message-ID: <20000827144403.WFLF209966.mta5-rme.xtra.co.nz@oemcomputer> X-Trace: niobium.hgmp.mrc.ac.uk 967387442 10524 193.62.192.80 (27 Aug 2000 14:44:02 GMT) X-Complaints-To: news@net.bio.net X-Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 38B2F17AE1; Sun, 27 Aug 2000 15:44:00 +0100 (BST) X-Received: from mta5-rme.xtra.co.nz (mta5-rme.xtra.co.nz [203.96.92.17]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 37859415EB for ; Sun, 27 Aug 2000 15:43:57 +0100 (BST) X-Received: from oemcomputer ([210.55.118.135]) by mta5-rme.xtra.co.nz (InterMail vM.4.01.02.17 201-229-119) with SMTP id <20000827144403.WFLF209966.mta5-rme.xtra.co.nz@oemcomputer>; Mon, 28 Aug 2000 02:44:03 +1200 X-To: cnmm11news@bolt.com To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk THE WALL STREET WIZARD NEWSLETTER FOR WEEK of August 28 to September 1, 2000 Early Release (Friday at 5 p.m.) to Members Only! OUR STOCK PICK Early Release To BE Sent ONLY to: Members, Group Leaders, Newsletter Owners and Financial Institution Managers Only! NEWS & STRONG BUY ALERT: UVGI otc-bb United Ventures Group STRONG BUY RECOMMENDATION UVGI Closed on Friday, August 25 at .135 for a GAIN of 8 % ! UVGI Closed on Thursday, August 24 at .125 for a GAIN of 15% ! Target is $1.00 Short Term UVGI has Doubled Their Revenue UVGI has more than doubled their Profit UVGI Reached a High of .95 on February 9, 2000 and closed that day at .80 UVGI REVENUES AND GROSS PROFITS HAVE DOUBLED & INCOME IS ALMOST ONE MILLION DOLLARS EXTREMELY STRONG BUY FOR THESE REASONS: #1 - HUGE INCREASE IN REVENUE PROJECTIONS #2 - BIG DEMAND FROM ELECTRONIC SHOPPING NETWORKS #3 - REDUCED PRODUCTION EXPENSES #4 - SALES TO MOST OF THE WORLDS LARGEST DEPARTMENT STORES #5 - FULLY REPORTING STATUS #6 - ALLIANCE WITH DOPPLET & GREENWALD DIAMONDS #7 - PROSPECTS OF ELEGANTCHOICE.COM WITH STRATEGIC ALLIANCES #8 - AGGRESSIVE COMPANY ACQUISITION PLAN #9 - FIFTY YEARS OF JEWELRY MANAGEMENT EXPERIENCE BETWEEN EXECUTIVES NUSSEN & WEISZ ----------------- Wednesday August 23, 3:43 pm Eastern Time Press Release United Ventures Group Poised to Launch Corporate Investor Web Site New Web Site to be Launched On August 28, 2000 NEW YORK--(BUSINESS WIRE)--Aug. 22, 2000--United Ventures Group (OTCBB:UVGI - news), a premier designer, manufacturer and distributor of fine jewelry, today announced that it will launch its new Corporate Investor Web site on August 28, 2000. The Web site will be updated on a regular basis and can be accessed at the address www.UVGIINVESTOR.com The new Web site, intended for the investment community will feature current and archived filings with the Securities and Exchange Commission, press releases, real time quotes and corporate information. The Web site will be the premier information source for current investors and potential investors wishing to make informed investment decisions about United Ventures Group. For Full Newsrelease go to: http://biz.yahoo.com/bw/000823/ny_united_.html ------------------------------------------------------------ Tuesday August 15, 7:00 am Eastern Time Press Release United Ventures Group Reports Results for the Six Months Ended June 30, 2000 Company Reports Record Net Income NEW YORK--(BUSINESS WIRE)--Aug. 15, 2000--United Ventures Group, Inc. (OTC BB:UVGI - news), a premier designer, manufacturer and distributor of fine jewelry, today reported results for the second quarter ended June 30, 2000. For the six months ended June 30, 2000 net sales were $5,874,404 versus $3,028,642 for the six months ended June 30, 1999. Gross profit increased from $782,494 to $1,623,622 for the first six months of 2000. Income from operations increased to $951,043 from a loss of $2,108,477. Net income rose to $370,749 for the six months ended June 30th compared to a loss of $3,888,619 for the comparable period in 1999. Isaac Nussen, President and CEO, stated, ``It is evident that during the second quarter and first six months of 2000 the Company made tremendous strides in a return to profitability. Net assets as of June 30, 2000 were $7.2 million. This coupled with our return to the OTC Bulletin Board, gaining status as a fully-reporting entity, increasing gross profit, and the commencement of an aggressive implementation of our strategic plan, we believe will garner long term shareholder value.'' ``I look forward to the Company's announced teleconference tomorrow which will be part of the UVGI's regular reporting process and demonstrates management's efforts to keep our loyal shareholder base informed,'' Nussen concluded. UVGI, a Delaware Corporation, through its wholly owned subsidiaries, is a jewelry designer, manufacturer and distributor. The Company's product line includes a wide assortment of 14-karat gold jewelry along with the newly added diamond, pearl and platinum jewelry lines. The Company is currently seeking to align itself with major Internet marketing and advertising entities to increase the brand awareness and drive traffic to the site. This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities and Litigation Reform Act of 1995. Expression of future goals and similar expressions reflecting something other than historical fact involve risks and uncertainties. The actual results the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. ----------------------------------------------- Contact: United Ventures Group, Inc. by DeMonte Associates Cynthia DeMonte, 212/473-3700 cdemonte@demonte.com ------------------------------------ The Wallstreet Wizard Newsletter makes no recommendation about the securities profiled here and this is not a solicitation to buy any of these. Management and staff may buy, sell or hold any of these securities mentioned. The material supplied is our opinion and is factual to the best of our knowledge and for information purposes only. For Free Trial to WallStreetU Newsletter: email to: stockw1@excite.com This email is NOT spam. You have received this email because either you, or someone claming tobe you has subscribed your email address to this list. To unsubscribe, simply email us at stockw2@excite.com and type "remove from the wallstreet wizard list" in the subject,(include a copy of this email) and your address will be removed from the newsletter email list ............................... MULTIPLY YOUR INVESTMENT DOLLAR WITH THIS GREAT STOCK OPPORTUNITY ---REVENUES AND GROSS PROFITS HAVE DOUBLED & INCOME IS ALMOST ONE MILLION DOLLARS-IT is About to EXPLODE in Share Price! More BREAKING News and Information on UVGI http://quote.yahoo.com/q?s=UVGI.OB&d=v1 http://www.ragingbull.altavista.com/mboard/boards.cgi?board=UVGI&read=31576>http://www.ragingbull.altavista.com/mboard/boards.cgi?board=UVGI&read=31576 -- --- From owner-cardiors@hgmp.mrc.ac.uk Mon Aug 28 20:00:15 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id DF8FF17A93; Mon, 28 Aug 2000 20:00:12 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id D7E5117A82; Mon, 28 Aug 2000 20:00:10 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 39FE3415DC; Mon, 28 Aug 2000 20:00:10 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id UAA09759; Mon, 28 Aug 2000 20:00:09 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Mary Wagner X-Newsgroups: bionet.biology.cardiovascular,bionet.cellbiol,bionet.neuroscience,bionet.software,sci.engr.biomed,sci.research Subject: Axon Instruments digidata 1200 board needed Date: Mon, 28 Aug 2000 14:45:36 -0400 Organization: Emory University Lines: 20 Message-ID: <39AAB350.19D2ED22@cellbio.emory.edu> Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Trace: lendl.cc.emory.edu 967488331 5675 170.140.101.107 (28 Aug 2000 18:45:31 GMT) X-Complaints-To: abuse@emory.edu X-Mailer: Mozilla 4.5 [en] (Win95; U) X-Accept-Language: en,pdf To: bio-software@hgmp.mrc.ac.uk, cardiors@hgmp.mrc.ac.uk, cellbiol@hgmp.mrc.ac.uk, neur-sci@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Hi all... Sorry for the crosspost. We had a computer stolen this weekend that included the board to out Axon Instruments Digidata 1200A. We have custom software and need to replace this board - does anyone have any idea where I can get my hands on a digidata 1200A board? Axon no longer makes the 1200 and has shipped their last 1200AE board. Thanks for any info! Reply here or to my email: mwagner@cellbio.emory.edu Oh, and suggestions on where else to ask would be great! Mary ______________________________________________ Mary Wagner, PhD Department of Pediatrics Emory University, Atlanta GA From owner-cardiors@hgmp.mrc.ac.uk Thu Aug 31 11:46:58 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 4751417AC4; Thu, 31 Aug 2000 11:46:58 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024) id 90F6717AC0; Thu, 31 Aug 2000 11:46:56 +0100 (BST) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id B3B52415D4 for ; Thu, 31 Aug 2000 11:46:55 +0100 (BST) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id LAA22279 for cardiors-list@hgmp.mrc.ac.uk; Thu, 31 Aug 2000 11:46:55 +0100 (BST) X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "Intermezzo" X-Newsgroups: bionet.biology.cardiovascular Subject: European Pectens Date: Thu, 31 Aug 2000 11:40:18 +0100 Lines: 27 Message-ID: <8olcpd$k2r$1@venus.telepac.pt> X-Trace: venus.telepac.pt 967718509 20571 212.55.175.72 (31 Aug 2000 10:41:49 GMT) X-Complaints-To: abuse@mail.telepac.pt X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.2417.2000 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2314.1300 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk We had recently released an interactiv cd-rom about the european pectens. In this site you can reach some information about them and about the cd, and how to order it. visit us at http://www.intermezzo.pt/pectens http://www.intermezzo.pt/pectens http://www.intermezzo.pt/pectens more informations intermezzo@intermezzo.pt Recentemente lancámos um cd-rom interactivo intitulado "Vieiras - Pectens da Europa". Aqui terá acesso a várias informações sobre estas pectens podendo também proceder à encomenda do cd-rom. visite-nos em: http://www.intermezzo.pt/pectens http://www.intermezzo.pt/pectens http://www.intermezzo.pt/pectens mais informações intermezzo@intermezzo.pt